NCT00090324已完成3 期
A 6-week, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Phase 3b Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL™) Immediate-release Tablets Compared With Placebo in Adolescents With Schizophrenia (Abbreviated)
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 249
- 试验地点
- 43
- 主要终点
- Compare efficacy of Quetiapine with placebo in the treatment of schizophrenia as assessed by the PANSS total score, change from baseline to Day 42
研究概览
简要总结
The purpose of this study is to demonstrate efficacy and safety of quetiapine fumarate (SEROQUEL) compared with placebo in the treatment of adolescent patients with schizophrenia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 13 Years 至 17 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient is able to provide written assent and the parents or legal guardian of the patient is able to provide written informed consent before beginning and study related procedures
- •Patient has a documented clinical diagnosis of schizophrenia
- •Patient's parent or legal guardian will be able to accompany the patient at each scheduled study visit
排除标准
- •Patients (female) must not be pregnant or lactating
- •Patients with a known intolerance or lack of response to previous treatment with quetiapine
- •Patients who have previously participated in this study
结局指标
主要结局
Compare efficacy of Quetiapine with placebo in the treatment of schizophrenia as assessed by the PANSS total score, change from baseline to Day 42
次要结局
- Compare the effect of Quetiapine with placebo in change from baseline to Day 42 level of functioning, evaluate aggression and hostility; evaluate safety and tolerability
研究者
研究点 (43)
Loading locations...
相似试验
已完成
3 期
Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I ManiaBipolar DisorderNCT00090311AstraZeneca220
已完成
3 期
Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar DisorderAlcohol DependenceBipolar I DisorderNCT00114686AstraZeneca350
已完成
3 期
Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I DisorderSchizophreniaBipolar I DisorderNCT00227305AstraZeneca381
已完成
4 期
Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute SchizophrenicSchizophreniaNCT00428350AstraZeneca120
已完成
3 期
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety DisorderGeneralized Anxiety DisorderNCT00329264AstraZeneca876